Stada Arzneimittel AG’s private equity owners are pushing back a planned initial public offering of the German drugmaker ...

Twenty U.S. states including California, Connecticut and Michigan have pushed back against a $10 million settlement that ...

The transaction is expected to close in the second quarter of 2025, which will include AstraZeneca will buying all ...

A federal judge granted summary judgment in favor of Merck for part of the litigation involving the HPV vaccine, Gardasil.

The plant will make three types of insulin, which Civica has pledged to sell for $30 a vial and $55 for a box of five pens. In 2023, Civica struck a deal to produce insulin for the state of California ...

"Billionaire" and "successful hedge fund manager" are titles that carry significant weight on Wall Street. These and others ...

Shares of Incyte sank Monday, making it the biggest decliner in the S&P 500 after the release of its latest clinical trial.

Pharma group Hikma looks to take advantage as Novo Nordisk’s Wegovy and Ozempic start to go off patent next year ...

Three senators are calling on Health and Human Services Secretary Robert F. Kennedy Jr. to disclose what he and President ...

Even as Novartis takes home a partial win in court tied to its key blockbuster Entresto, the Swiss drugmaker continues to tighten its belt in anticipation of a generic heart med incursion later thi | ...

The vote clears the way for a proposed multibillion-dollar expansion of the former Nexus Pharmaceuticals facility.